Carotid artery stenosis – Current evidence and treatment recommendations
Open Access
- 1 January 2021
- journal article
- review article
- Published by MDPI AG in Clinical and Translational Neuroscience
Abstract
Background: Carotid artery stenosis is an important cause for stroke. Carotid endarterectomy (CEA) reduces the risk of stroke in patients with symptomatic carotid stenosis and to some extent in patients with asymptomatic carotid stenosis. More than 20 years ago, carotid artery stenting (CAS) emerged as an endovascular treatment alternative to CEA. Objective and Methods: This review summarises the available evidence from randomised clinical trials in patients with symptomatic as well as in patients with asymptomatic carotid stenosis. Results: CAS is associated with a higher risk of death or any stroke between randomisation and 30 days after treatment than CEA (odds ratio (OR) = 1.74, 95% CI 1.3 to 2.33, p < 0.0001). In a pre-defined subgroup analysis, the OR for stroke or death within 30 days after treatment was 1.11 (95% CI 0.74 to 1.64) in patients <70 years old and 2.23 (95% CI 1.61 to 3.08) in patients ≥70 years old, resulting in a significant interaction between patient age and treatment modality (interaction p = 0.007). The combination of death or any stroke up to 30 days after treatment or ipsilateral stroke during follow-up also favoured CEA (OR = 1.51, 95% CI 1.24 to 1.85, p < 0.0001). In asymptomatic patients, there is a non-significant increase in death or stroke occurring within 30 days of treatment with CAS compared to CEA (OR = 1.72, 95% CI 1.00 to 2.97, p = 0.05). The risk of peri-procedural death or stroke or ipsilateral stroke during follow-up did not differ significantly between treatments (OR = 1.27, 95% CI 0.87 to 1.84, p = 0.22). Discussion and Conclusion: In symptomatic patients, randomised evidence has consistently shown CAS to be associated with a higher risk of stroke or death within 30 days of treatment than CEA. This extra risk is mostly attributed to an increase in strokes occurring on the day of the procedure in patients ≥70 years. In asymptomatic patients, there may be a small increase in the risk of stroke or death within 30 days of treatment with CAS compared to CEA, but the currently available evidence is insufficient and further data from ongoing randomised trials are needed.This publication has 48 references indexed in Scilit:
- Carotid plaque hemorrhage on magnetic resonance imaging strongly predicts recurrent ischemia and strokeAnnals of Neurology, 2013
- 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trialThe Lancet, 2010
- Concept of Vulnerable/Unstable PlaqueArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Prevalence of Asymptomatic Carotid Artery Stenosis in the General PopulationStroke, 2010
- From subgroups to individuals: general principles and the example of carotid endarterectomyThe Lancet, 2005
- Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgeryThe Lancet, 2004
- Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosisThe Lancet, 2003
- Classification of Human Carotid Atherosclerotic Lesions With In Vivo Multicontrast Magnetic Resonance ImagingJournal of the American College of Cardiology, 2002
- Contrast‐enhanced high resolution MRI for atherosclerotic carotid artery tissue characterizationJournal of Magnetic Resonance Imaging, 2002
- Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST)The Lancet, 1998